Director exercised or converted 38 TECH derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Feb 3, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Feb 5, 2026
DirectorIndirect holdingOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Filed / recordedFeb 5, 2026, 11:30 PM UTC Added to OQROOct 2, 2026, 12:27 PM UTC Data qualityVerified: identifiers matched exactly Reporting personAmy E. Herr SecurityRestricted Stock Units TableDerivative (Table II) Transaction dateFeb 3, 2026 Acquired / disposedDisposed (D) Ownership formIndirect — By significant other Footnotes from the filing
- Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- 38 restricted stock units vest on each of 2/3/2026 and 2/3/2027, and 39 restricted stock units vest on 2/3/2028.
Around the same time
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.